I think they should at least publicly try and get a partner or sell. Further dilution isn't fair to the stock holders. Most everyone recognizes the drug has good potential sales.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.